Authors:
PICHERT G
SCHMITTER D
WIDMER L
JOST LM
KURRER MO
MAURER R
STAHEL RA
Citation: G. Pichert et al., SELECTION AND IMMUNOMAGNETIC PURGING OF PERIPHERAL-BLOOD CD34-CELL NON-HODGKINS-LYMPHOMAS( CELLS FOR AUTOLOGOUS TRANSPLANTATION IN B), Annals of oncology, 9(1), 1998, pp. 51-54
Citation: Lm. Jost et al., INDEX OF PRETREATMENT INTENSITY PREDICTS OUTCOME OF HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS PROGENITOR-CELL TRANSPLANTATION IN CHEMOSENSITIVERELAPSE OF HODGKINS-DISEASE, Annals of oncology, 8(8), 1997, pp. 785-790
Authors:
STAHEL RA
JOST LM
HONEGGER H
BETTS E
GOEBEL MEM
NAGLER A
Citation: Ra. Stahel et al., RANDOMIZED TRIAL SHOWING EQUIVALENT EFFICACY OF FILGRASTIM 5 MU-G KG/D AND 10 MU-G/KG/D FOLLOWING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN HIGH-RISK LYMPHOMAS/, Journal of clinical oncology, 15(5), 1997, pp. 1730-1735
Citation: L. Widmer et al., FATE OF CONTAMINATING T(14-18)(-CELLS DURING EX-VIVO EXPANSION OF CD34-SELECTED HEMATOPOIETIC PROGENITOR CELLS() LYMPHOMA), Blood, 88(8), 1996, pp. 3166-3175
Authors:
JOST LM
JACKY E
DOMMANNSCHERRER C
HONEGGER HP
MAURER R
SAUTER C
STAHEL RA
Citation: Lm. Jost et al., SHORT-TERM WEEKLY CHEMOTHERAPY FOLLOWED BY HIGH-DOSE THERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR LYMPHOBLASTIC AND BURKITT LYMPHOMAS IN ADULT PATIENTS, Annals of oncology, 6(5), 1995, pp. 445-451
Citation: Ra. Stahel et al., HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FORMALIGNANT-LYMPHOMAS, Cancer treatment reviews, 21(1), 1995, pp. 3-32
Citation: L. Widmer et al., AUTOLOGOUS TRANSPLANTATION OF CD34-SELECTED AND IMMUNOMAGNETICALLY PURGED HEMATOPOIETIC PROGENITOR CELLS MEDIATES RAPID HEMATOLOGICAL RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY IN PATIENTS WITH FOLLICULAR LYMPHOMA(), Blood, 86(10), 1995, pp. 9145-9145
Authors:
STAHEL RA
JOST LM
CERNY T
PICHERT G
HONEGGER H
TOBLER A
JACKY E
FEY M
PLATZER E
Citation: Ra. Stahel et al., RANDOMIZED STUDY OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HIGH-RISK LYMPHOID MALIGNANCIES, Journal of clinical oncology, 12(9), 1994, pp. 1931-1938
Authors:
JOST LM
PICHERT G
REICHLIN M
MULLER E
JACKY E
HONEGGER HP
GMUR J
STAHEL RA
Citation: Lm. Jost et al., 5 YEARS OF DOSE INTENSIFICATION AND AUTOLOGOUS BONE-MARROW OR PERIPHERAL STEM-CELL TRANSPLANTATION IN MALIGNANT-LYMPHOMA WITH HIGH-RISK OF RELAPSE, Schweizerische medizinische Wochenschrift, 123(18), 1993, pp. 932-940